Patient in their 40s with unexplained myocardial hypertrophy

Summary: Fabry disease is a lysosomal disorder that causes the accumulation of glycosphingolipids, leading to organ damage and reduced life expectancy. Treatment goals should be individualized based on the phenotype and severity of the disease. Expert consensus and literature review were used to develop practical clinical recommendations for disease and organ-specific therapeutic goals in Fabry disease.